Hematology-Oncology Associates of the Quad-Cities, PC
Bladder Cancer Trials
CALGB 90601 A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin and Bevacizumab To Gemcitabine, Cisplatin and Placebo in Patients With Advanced Transistional Cell Carcinoma
